首页 › 慢性阻塞性肺病 › 南达科他州 › Rapid City
Rapid City SD 慢性阻塞性肺病临床试验
5项针对 慢性阻塞性肺病的研究正在 Rapid City及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
招募中3 期
- Research Site, Rapid City
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
招募中3 期
- GSK Investigational Site, Rapid City
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
招募中2 期
- Research Site, Rapid City
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
招募中3 期
- Research Site, Rapid City
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
招募中2/3 期
- Health Concepts, Rapid City
其他城市的 慢性阻塞性肺病试验
- Philadelphia, PA24 项研究
- Miami, FL18 项研究
- Birmingham, AL17 项研究
- Boston, MA17 项研究
- Houston, TX16 项研究
- Baltimore, MD15 项研究
- Orlando, FL15 项研究
- Chicago, IL15 项研究
- Dallas, TX13 项研究
- Pittsburgh, PA12 项研究
- New York City, NY11 项研究
- Ann Arbor, MI10 项研究
Rapid City的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。